Blood Concentrations of Cyclosporin A during Long-Term Treatment with Cyclosporin A Ophthalmic Emulsions in Patients with Moderate to Severe Dry Eye Disease

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 5, 2002, Pages 411-418

  Small, David S ^a,b   Acheampong, Andrew ^a   Reis, Brenda ^a,c   Stern, Katherine ^a   Stewart, William ^d   Berdy, Gregg ^e   Epstein, Randy ^f   Foerster, Robert ^g   Forstot, Lance ^h   Tang Liu, Diane D S ^a  

^a ALLERGAN INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Wyeth Ayerst Corp   (United States)

^d University of South Carolina   (United States)

^e Rush Presbyterian St Luke’s Medical Center ^*  (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g NONE   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT; ARTIFICIAL TEAR; CYCLOSPORIN A; REFRESH;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INSTILLATION; EMULSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; BLOOD SAMPLING; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRY EYE; LONG TERM CARE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DOUBLE-BLIND METHOD; EMULSIONS; FEMALE; HUMANS; INSTILLATION, DRUG; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS;

EID: 0036779473     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/10807680260362696     Document Type: Article

References (13)

1. Nelson, J.D., Helms, H., Fiscella, R., Southwell, Y., and Hirsch, J.D. A new look at dry eye disease and its treatment. Adv. Ther. 17:84-93, 2000.
2. Kozma, C.M., Hirsch, J.D., and Wojcik, A.R. Economic and quality of life impact of dry eye symptoms. Invest. Ophthalmol. Vis. Sci. 41(4):S928, 2000. Abstract nr 4933.
3. Pflugfelder, S.C., Solomon, A., and Stern, M.E. The diagnosis and management of dry eye: A twenty-five-year review. Cornea. 19:644-649, 2000.
4. Stern, M.E., Beuerman, R.W., Fox, R.I., Gao, J.G., Mircheff, A.K., and Pflugfelder, S.C. The pathology of dry eye: The interaction between the ocular surface and lacrimal glands. Cornea. 17:584-589, 1998.
5. Brignole, F., Pisella, P.J., De Saint Jean, M., Goldschild, M., Goguel, A., and Baudouin, C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest. Ophthalmol. Vis. Sci. 42:90-95, 2001.
6. Kunert, K.S., Tisdale, A.S., Stern, M.E., Smith, J.A., and Gipson, I.K. Analysis of topical cyclosporine treatment of patients with dry eye syndrome. Arch. Ophthalmol. 118:1489-1496, 2000.
7. Turner, K., Pflugfelder, S.C., Ji, Z., Feuer, W.J., Stern, M.E., and Reis, B.L. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 19:492-496, 2000.
8. Stevenson, D., Tauber, J., Reis, B.L., and the Cyclosporin A Phase 2 Study Group. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial. Ophthalmol. 107:967-974, 2000.
9. Sall, K., Stevenson, O.D., Mundorf, T., Reis, B.L., and the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmol. 107:631-638, 2000.
10. th edition. Medical Economics Company, Montvale, NJ, 2000.
11. Schiffman, R.M., Christianson, M.D., Jacobson, G., Hirsch, J.D., and Reis, B.L. Reliability and validity of the Ocular Surface Disease Index., Archiv. Ophthalmol. 118:615-621, 2000.
12. Gibaldi, M., and Perrier, D. Pharmacokinetics. 2nd ed. Marcel Dekker, Inc., New York, NY, 1982.
13. Acheampong, A., Shackleton, M., Tang-Liu, D.S., Ding, S., Stern, M.E., and Decker, R. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr. Eye Res. 18:91-103, 1999.